Daymark Wealth Partners’s Boston Scientific BSX Stock Holding History

Daymark Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$316K	Sell	7,396 -2,102	-22%	-$114K	0.01%	614
2026 Q1	$596K	Buy	9,498 +3,810	+67%	+$305K	0.02%	376
2025 Q4	$542K	Buy	5,688 +717	+14%	+$70.3K	0.02%	373
2025 Q3	$485K	Buy	4,971 +151	+3%	+$15.6K	0.02%	388
2025 Q2	$518K	Buy	4,820 +961	+25%	+$97.2K	0.02%	346
2025 Q1	$389K	Sell	3,859 -122	-3%	-$12.3K	0.02%	367
2024 Q4	$356K	Buy	3,981 +627	+19%	+$55.2K	0.02%	381
2024 Q3	$281K	Buy	+3,354	New	+$264K	0.01%	435

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Daymark Wealth Partners's BSX Position: Q2 2026 in Review

Daymark Wealth Partners reduced its Boston Scientific (BSX) stake by 22% in Q2 2026, selling an estimated $114K and leaving 7,396 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #614.

Daymark Wealth Partners first reported a position in BSX in Q3 2024 and has held it in 8 quarters since. The position peaked at $596K in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Daymark Wealth Partners held 7,396 shares of Boston Scientific worth $316K as of Q2 2026.
Daymark Wealth Partners sold 2,102 Boston Scientific shares in Q2 2026, an estimated $114K.
Boston Scientific made up 0.01% of Daymark Wealth Partners's portfolio in Q2 2026, its #614 holding.
Daymark Wealth Partners first reported a position in Boston Scientific in Q3 2024 and has held it in 8 quarters since.
Daymark Wealth Partners's Boston Scientific position peaked at $596K in Q1 2026.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.